- Corporate Governance
- Information to the Swedish Markets
- Annual Reports
- Management Bios
- News Releases
- Stock Information
- SEC Filings
- Events & Presentations
- Request Information
- Contact Us
Download Library
Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files.
| Title | Date | Type | Size | ||||
|---|---|---|---|---|---|---|---|
| Corporate Presentation – January 2012 |
|
665.3 KB | |||||
| EpiCept Compliance with the Swedish Corporate Governance Code |
|
111.6 KB | |||||
| 2010 Annual Report |
|
3.7 MB | |||||
| 2011 Proxy Report |
|
583.7 KB | |||||
| Rodman and Renshaw Presentation – May 2010 |
|
1.8 MB | |||||
| 2009 Annual Report |
|
4.6 MB | |||||
| 2010 Proxy Report | 2008 |
|
605.2 KB | ||||
| EpiCept tillhandahåller uppdateringar för kliniska och regelmässiga framsteg med Ceplene™ och EpiCept™ NP-1-kräm |
|
11.1 KB | |||||
| 2008 Annual Report | 2007 |
|
1.2 MB | ||||
| EpiCept publicerar nya data som påvisar en femårig förlängd leukemifri överlevnad för AML-patienter som behandlats med Ceplene™ + IL-2 |
|
9.6 KB | |||||
|
|||||||
|
|
|
|
|
|